男友太凶猛1v1高h,大地资源在线资源免费观看 ,人妻少妇精品视频二区,极度sm残忍bdsm变态

Global EditionASIA 中文雙語Fran?ais
Business
Home / Business / Companies

AstraZeneca announces medical AI cooperation with Chinese companies

By ZHENG YIRAN | chinadaily.com.cn | Updated: 2020-07-02 16:25
Share
Share - WeChat
The AstraZeneca logo. [Photo/astrazeneca.com.cn]

During the upcoming 2020 World Artificial Intelligence Conference in Shanghai, United Kingdom-based pharmaceutical company AstraZeneca said it will launch 10 major application scenarios integrating AI with healthcare, further boosting its cooperation in innovation with Chinese companies, said a senior official.

Leon Wang, executive vice-president and China president at AstraZeneca, said for the 2020 WAIC, which will be held between July 9 and 11, the company will reveal the latest applications of AI in the healthcare sector, covering scenarios including pharmaceutical research and development, drug production, diagnosis and treatment, and the company is open to cooperation opportunities with Chinese firms.

"Through the cooperation, with the help of advanced technologies such as machine vision, prediction algorithms and natural language understanding, we hope to explore deeply into the processes including screening, diagnosis, treatment and patient follow-up. In this way, we are able to promote the application of AI in various diseases, fully increase work efficiency and benefit Chinese patients better," he said.

It is estimated the company may announce the cooperation and innovative achievements by the WAIC next year, he added.

To foster innovative cooperation with Chinese companies, with the help of the local government, last year AstraZeneca built the Wuxi International Life Science Innovation Campus in Wuxi, Jiangsu province. According to the company, it plans to launch more life science innovation campuses in more cities in the future, including Beijing, Shanghai, Guangzhou, Chengdu and Hangzhou.

Working with China International Capital Corp Ltd, AstraZeneca launched a medical fund worth $1 billion. The fund was raised to invest in medical innovation in China.

Currently, the first phase of fundraising is completed. It is estimated the fund will start to use this year to assist Chinese innovative enterprises, Wang said.

CICC said AI is changing the world, and has become an inevitable trend. The company will focus on the latest application of AI and promote the exploration and landing of applications.

Top
BACK TO THE TOP
English
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
CLOSE
 
主站蜘蛛池模板: 柳州市| 宜昌市| 德兴市| 林西县| 隆昌县| 嘉善县| 仙居县| 镇远县| 合江县| 施甸县| 中方县| 陵水| 香河县| 吴川市| 清水县| 高安市| 利津县| 蒙阴县| 拉萨市| 四会市| 蒲城县| 忻州市| 樟树市| 英吉沙县| 灵丘县| 方正县| 呼玛县| 乐业县| 静安区| 富顺县| 肇东市| 同心县| 平罗县| 湛江市| 绿春县| 定安县| 乡城县| 邛崃市| 八宿县| 自治县| 长兴县|